• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素受体在小鼠皮质质膜隔室中的分布。

Cannabinoid receptors distribution in mouse cortical plasma membrane compartments.

机构信息

Department of Anatomy, Physiology, Pharmacology; College of Medicine, University of Saskatchewan, 105 Wiggins Road, Health Sciences Bldg. Room GD30.5, Saskatoon, SK, S7N 5E5, Canada.

College of Pharmacy and Nutrition, University of Saskatchewan, 105 Wiggins Road, Health Sciences Bldg. Room 3B36, Saskatoon, SK, S7N 5E5, Canada.

出版信息

Mol Brain. 2021 Jun 7;14(1):89. doi: 10.1186/s13041-021-00801-x.

DOI:10.1186/s13041-021-00801-x
PMID:34099009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8183067/
Abstract

The type 1 and type 2 cannabinoid receptors (CB1 and CB2 receptors) are class A G protein-coupled receptors (GPCRs) that are activated by endogenous lipids called endocannabinoids to modulate neuronal excitability and synaptic transmission in neurons throughout the central nervous system (CNS), and inflammatory processes throughout the body. CB1 receptor is one of the most abundant GPCRs in the CNS and is involved in many physiological and pathophysiological processes, including mood, appetite, and nociception. CB2 receptor is primarily found on immunomodulatory cells of both the CNS and the peripheral immune system. In this study, we isolated lipid raft and non-lipid raft fractions of plasma membrane (PM) from mouse cortical tissue by using cold non-ionic detergent and sucrose gradient centrifugation to study the localization of CB1 receptor and CB2 receptor. Lipid raft and non-lipid raft fractions were confirmed by flotillin-1, caveolin-1 and transferrin receptor as their protein biomarkers. Both CB1 receptor and CB2 receptor were found in non-raft compartments that is inconsistent with previous findings in cultured cell lines. This study demonstrates compartmentalization of both CB1 receptor and CB2 receptor in cortical tissue and warrants further investigation of CB1 receptor and CB2 receptor compartmental distribution in various brain regions and cell types.

摘要

1 型和 2 型大麻素受体(CB1 和 CB2 受体)是 A 类 G 蛋白偶联受体(GPCR),它们被称为内源性大麻素的内源性脂质激活,从而调节整个中枢神经系统(CNS)中神经元的兴奋性和突触传递,以及全身的炎症过程。CB1 受体是 CNS 中最丰富的 GPCR 之一,参与许多生理和病理生理过程,包括情绪、食欲和痛觉。CB2 受体主要存在于 CNS 和外周免疫系统的免疫调节细胞上。在这项研究中,我们使用冷非离子去污剂和蔗糖梯度离心从鼠皮质组织中分离出质膜(PM)的脂筏和非脂筏部分,以研究 CB1 受体和 CB2 受体的定位。脂筏和非脂筏部分通过 flotillin-1、caveolin-1 和转铁蛋白受体作为其蛋白生物标志物得到证实。CB1 受体和 CB2 受体都存在于非筏状隔室中,这与先前在培养细胞系中的发现不一致。这项研究表明 CB1 受体和 CB2 受体在皮质组织中的隔室化,并需要进一步研究 CB1 受体和 CB2 受体在不同脑区和细胞类型中的隔室分布。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4622/8183067/4bf5fb3746e2/13041_2021_801_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4622/8183067/09758004c1bb/13041_2021_801_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4622/8183067/4bf5fb3746e2/13041_2021_801_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4622/8183067/09758004c1bb/13041_2021_801_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4622/8183067/4bf5fb3746e2/13041_2021_801_Fig2_HTML.jpg

相似文献

1
Cannabinoid receptors distribution in mouse cortical plasma membrane compartments.大麻素受体在小鼠皮质质膜隔室中的分布。
Mol Brain. 2021 Jun 7;14(1):89. doi: 10.1186/s13041-021-00801-x.
2
Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line.内源性大麻素在背根神经节细胞系中分隔到脂筏中。
Br J Pharmacol. 2008 Jan;153(2):380-9. doi: 10.1038/sj.bjp.0707561. Epub 2007 Oct 29.
3
Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1.内源性大麻素在缺乏窖蛋白-1 的小胶质细胞系中脂质筏的区室化。
Br J Pharmacol. 2012 Apr;165(8):2436-49. doi: 10.1111/j.1476-5381.2011.01380.x.
4
Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors.粒细胞集落刺激因子增强创伤性脑损伤后的脑修复,而无需激活大麻素受体。
Cannabis Cannabinoid Res. 2021 Feb 12;6(1):48-57. doi: 10.1089/can.2019.0090. eCollection 2021.
5
Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.衰老过程中2-花生四烯酸甘油酯的大麻素受体依赖性代谢
Exp Gerontol. 2014 Jul;55:134-42. doi: 10.1016/j.exger.2014.04.008. Epub 2014 Apr 24.
6
Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis.脂筏调控神经元细胞中1型大麻素受体的信号传导。对花生四烯酸乙醇胺诱导的细胞凋亡的影响。
J Biol Chem. 2005 Apr 1;280(13):12212-20. doi: 10.1074/jbc.M411642200. Epub 2005 Jan 18.
7
The pharmacology of cannabinoid receptors and their ligands: an overview.大麻素受体及其配体的药理学:概述
Int J Obes (Lond). 2006 Apr;30 Suppl 1:S13-8. doi: 10.1038/sj.ijo.0803272.
8
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.在体外,大麻二酚作为CB1和CB2受体激动剂的拮抗剂,显示出出乎意料的高效能。
Br J Pharmacol. 2007 Mar;150(5):613-23. doi: 10.1038/sj.bjp.0707133. Epub 2007 Jan 22.
9
Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing.大麻素受体在人结肠中的差异表达:大麻素促进上皮伤口愈合。
Gastroenterology. 2005 Aug;129(2):437-53. doi: 10.1016/j.gastro.2005.05.026.
10
Expression of GPR55 and either cannabinoid CB or CB heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates.在对照、帕金森病和运动障碍的非人类灵长类动物的尾状核、壳核和伏隔核核中表达 GPR55 和大麻素 CB 或 CB 异源受体复合物。
Brain Struct Funct. 2020 Sep;225(7):2153-2164. doi: 10.1007/s00429-020-02116-4. Epub 2020 Jul 20.

引用本文的文献

1
Efficacy and Safety of Cannabinoids for Autism Spectrum Disorder: An Updated Systematic Review.大麻素治疗自闭症谱系障碍的疗效与安全性:一项更新的系统评价
Cureus. 2025 Mar 17;17(3):e80725. doi: 10.7759/cureus.80725. eCollection 2025 Mar.
2
JWH-182: a safe and effective synthetic cannabinoid for chemotherapy-induced neuropathic pain in preclinical models.JWH-182:一种安全有效的合成大麻素,用于治疗临床前模型中的化疗引起的神经性疼痛。
Sci Rep. 2024 Jul 15;14(1):16242. doi: 10.1038/s41598-024-67154-y.
3
Milk-based culture of and its component oleamide affect cognitive function in healthy elderly Japanese individuals: a multi-arm randomized, double-blind, placebo-controlled study.

本文引用的文献

1
Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg.1 型大麻素受体的正变构调节可减少斯特拉斯堡遗传性癫痫大鼠的棘波和尖波放电。
Neuropharmacology. 2021 Jun 1;190:108553. doi: 10.1016/j.neuropharm.2021.108553. Epub 2021 Apr 9.
2
The ins and outs of lipid rafts: functions in intracellular cholesterol homeostasis, microparticles, and cell membranes: Thematic Review Series: Biology of Lipid Rafts.脂筏的来龙去脉:在细胞内胆固醇稳态、微粒及细胞膜中的功能:主题综述系列:脂筏生物学
J Lipid Res. 2020 May;61(5):676-686. doi: 10.1194/jlr.TR119000383. Epub 2020 Nov 7.
3
基于牛奶的培养物及其成分油酸酰胺对健康日本老年人认知功能的影响:一项多组随机、双盲、安慰剂对照研究。
Front Nutr. 2024 Mar 27;11:1357920. doi: 10.3389/fnut.2024.1357920. eCollection 2024.
4
The Healthy and Diseased Retina Seen through Neuron-Glia Interactions.通过神经元-胶质细胞相互作用观察健康和病变的视网膜。
Int J Mol Sci. 2024 Jan 17;25(2):1120. doi: 10.3390/ijms25021120.
5
Update on the controversial identity of cells expressing cnr2 gene in the nervous system.关于神经系统中表达 cnr2 基因的细胞的争议性身份的最新进展。
CNS Neurosci Ther. 2023 Mar;29(3):760-770. doi: 10.1111/cns.13977. Epub 2023 Jan 5.
6
Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits.2型大麻素受体:调节与精神分裂症相关脑回路的新兴靶点。
Front Neurosci. 2022 Aug 11;16:925792. doi: 10.3389/fnins.2022.925792. eCollection 2022.
7
Protective Effects of Cannabidiol on Chemotherapy-Induced Oral Mucositis via the Nrf2/Keap1/ARE Signaling Pathways.大麻二酚通过 Nrf2/Keap1/ARE 信号通路对化疗诱导的口腔黏膜炎的保护作用。
Oxid Med Cell Longev. 2022 May 25;2022:4619760. doi: 10.1155/2022/4619760. eCollection 2022.
8
Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination.医用大麻的神经学益处、临床挑战及神经病理学前景:对大麻素在多发性硬化症及脱髓鞘实验模型中作用的系统评价
Biomedicines. 2022 Feb 24;10(3):539. doi: 10.3390/biomedicines10030539.
9
Cannabidiol Promotes Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in the Inflammatory Microenvironment via the CB2-dependent p38 MAPK Signaling Pathway.大麻二酚通过CB2依赖性p38丝裂原活化蛋白激酶信号通路促进炎症微环境中骨髓间充质干细胞的成骨分化。
Int J Stem Cells. 2022 Nov 30;15(4):405-414. doi: 10.15283/ijsc21152. Epub 2022 Feb 28.
Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs.
靶向内源性大麻素 CB1 受体治疗体重紊乱:过去和现在 CB1 药物治疗潜力的临床前和临床综述。
Biomolecules. 2020 Jun 4;10(6):855. doi: 10.3390/biom10060855.
4
The Role of the Cannabinoid System in Pain Control: Basic and Clinical Implications.大麻素系统在疼痛控制中的作用:基础与临床意义。
Curr Pain Headache Rep. 2020 Jun 6;24(7):35. doi: 10.1007/s11916-020-00873-9.
5
Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice.外周 CB1 受体阻滞剂的抗肥胖治疗:从承诺到安全(?)实践。
Int J Obes (Lond). 2020 Nov;44(11):2179-2193. doi: 10.1038/s41366-020-0577-8. Epub 2020 Apr 21.
6
NOX2 is involved in CB2-mediated protection against lung ischemia-reperfusion injury in mice.NOX2参与了CB2介导的对小鼠肺缺血再灌注损伤的保护作用。
Int J Clin Exp Pathol. 2020 Feb 1;13(2):277-285. eCollection 2020.
7
Anti-apoptotic and Immunomodulatory Effect of CB2 Agonist, JWH133, in a Neonatal Rat Model of Hypoxic-Ischemic Encephalopathy.CB2激动剂JWH133在新生大鼠缺氧缺血性脑病模型中的抗凋亡和免疫调节作用
Front Pediatr. 2020 Feb 27;8:65. doi: 10.3389/fped.2020.00065. eCollection 2020.
8
Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review.基于大麻素治疗多发性硬化症的观点:一篇综述短文
Front Cell Neurosci. 2020 Feb 19;14:34. doi: 10.3389/fncel.2020.00034. eCollection 2020.
9
Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G Complex Structures.大麻素受体-G 复合物结构揭示的激活和信号转导机制。
Cell. 2020 Feb 20;180(4):655-665.e18. doi: 10.1016/j.cell.2020.01.008. Epub 2020 Jan 30.
10
TRIM34 localizes to the mitochondria and mediates apoptosis through the mitochondrial pathway in HEK293T cells.TRIM34定位于线粒体,并通过线粒体途径介导HEK293T细胞凋亡。
Heliyon. 2020 Jan 9;6(1):e03115. doi: 10.1016/j.heliyon.2019.e03115. eCollection 2020 Jan.